Mellanox buys Voltaire for $218 million

Company says combination strengthens its position as premier, end-to-end connectivity-solutions provider for growing worldwide data-center server and storage markets.

November 29, 2010 23:28
2 minute read.
Hi-tech employees meeting together.

computers 311. (photo credit:


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Semiconductor company Mellanox Technologies Ltd. has announced that it is buying fellow Israeli company Voltaire Ltd. for $218 million, or $8.75 per share ($176m. net of cash). The price represents a premium of 37 percent on Voltaire’s market price.

At the end of the third quarter, Mellanox had cash of $240m.

Be the first to know - Join our Facebook page.

The terms of the transaction have been unanimously approved by both the Mellanox and Voltaire boards of directors. The transaction is currently projected to close in the first quarter of 2011, subject to certain conditions.

Mellanox expects that the transaction will be accretive to its fiscal 2011 non-GAAP earnings by $0.02-$0.05 or more per share.

Mellanox said the combination of the two companies would strengthen its position as a premier, end-to-end connectivity- solutions provider for the growing worldwide data-center server and storage markets.

The company’s announcement cites research by Gartner showing that worldwide server shipments are expected to increase from approximately 9 million in 2010 to 11.2 million in 2014, and worldwide storage systems are expected to grow from about 1.8 million in 2010 to 3.2 million in 2014.

The combined businesses currently have some 700 employees and achieved revenues of $217m. for the 12 months ended September 30.

J.P. Morgan advised Mellanox in the transaction, and Bank of America Merrill Lynch advised Voltaire.

“The combination of Mellanox and Voltaire will create a leading provider of connectivity solutions for our customers by leveraging the complementary strengths of our companies,” Mellanox Technologies president, chairman and CEO Eyal Waldman said in a statement.

“Together, we believe the combined company will be a stronger business partner and system solutions provider, delivering customers a comprehensive range of end-to-end connectivity solutions. We welcome the great talent from Voltaire and look forward to completing the integration of our employees to create a superior combined company.”

Mellanox said the combination would also help it achieve annualized cost synergies of at least $10m. by the end of 2012, and it intends to combine employees from both organizations under one unified management team.

Mellanox’s board said it would nominate Voltaire chairman and CEO Ronnie Kenneth as a director.

“We believe this is a great transaction for our customers, employees and shareholders,” Kenneth said. “We expect the combined company to offer our customers the financial strength of Mellanox, industry-leading solutions and world-class development teams that drive innovation and enhance market opportunities.”

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection